Feedback
Full Name :  
Company :  
E-mail :  
Phone Number :  
Comments :  
   
   
 
EnColl Corporation
 
 
DERMAL / DENTAL
 
  Currently
US-FDA cleared
HELICOLL
US FDA K#040314
 
 
 
CARDIOVASCULAR / ORTHOPEDIC
 
 
STEMCELL AND GENE THERAPY
 
 
Click here
 
 
SKINCARE / NUTRITIONAL / VET.
 
EnColl Promotes its Cost Effective Wound Management HELICOLL Product in a Big Way..
 
Press Release: 1 Feb., 2014 2:13 PM (FREMONT, CALIFORNIA)
 

EnColl Corporation, established in 1994, has combined their three US patents for collagen processing with their proprietary technology for manufacturing of a highly purified, medical-grade, non-immunogenic, type-I collagen. In 2004 EnColl received FDA approval for the advanced collagen dressing product, HELICOLL. EnColl is certified under ISO 13485.

EnColl markets HELICOLL for treatment of wounds, burns, dermal abrasions, ulcers/sores, and tissue regeneration. HELICOLL's performance has been verified in the treatment of wounds and burns in a number of studies by Plastic, Podiatric, Orthopedic and General Surgeons. Helicoll has been used on more than 30,000 clinical cases without any adverse effects; and, HELICOLL has demonstrated 70 percent faster wound healing capacity. Importantly, HELICOLL is more cost effective than competitive products for the same applications. The product has a shelf life of three years at room temperature.

For more Information Please Contact:
S. Guna Gunasekaran, PhD
President - CEO
EnColl Corp.
4576 Enterprise Street,
Fremont, CA-94538, USA
e-mail: guna@encoll.com
www.encoll.com
Tel. 510-396-8581

Home  I  Corporate Info  I  Our Products  I  Place an Order  I  Research  I  Contact Us All Rights Reserved EnColl @ 2013